These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2598410)

  • 21. Induction of erythroid differentiation in vitro by purines and purine analogues.
    Gusella JF; Housman D
    Cell; 1976 Jun; 8(2):263-9. PubMed ID: 971485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel mechanism of mycophenolic acid resistance in the protozoan parasite Tritrichomonas foetus.
    Hedstrom L; Cheung KS; Wang CC
    Biochem Pharmacol; 1990 Jan; 39(1):151-60. PubMed ID: 1967525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism of deoxynucleosides by lymphocytes in long-term culture deficient in different purine enzymes.
    Simmonds HA; Goday A; Morris GS; Brolsma MF
    Biochem Pharmacol; 1984 Mar; 33(5):763-70. PubMed ID: 6424679
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
    Frank DA; Sartorelli AC
    Cancer Res; 1988 Jan; 48(1):52-8. PubMed ID: 2825968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A decrease in the intracellular guanosine 5'-triphosphate concentration is necessary for granulocytic differentiation of HL-60 cells, but growth cessation and differentiation are not associated with a change in the activation state of Ras, the transforming principle of HL-60 cells.
    Pilz RB; Huvar I; Scheele JS; Van den Berghe G; Boss GR
    Cell Growth Differ; 1997 Jan; 8(1):53-9. PubMed ID: 8993834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical assay of inhibitors of metabolic cooperation.
    Vitkauskas G; Kole J; Canellakis ES
    Exp Cell Res; 1983 Apr; 145(1):15-30. PubMed ID: 6852123
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical severity in Lesch-Nyhan disease: the role of residual enzyme and compensatory pathways.
    Fu R; Sutcliffe D; Zhao H; Huang X; Schretlen DJ; Benkovic S; Jinnah HA
    Mol Genet Metab; 2015 Jan; 114(1):55-61. PubMed ID: 25481104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enzymic capacities of purine de Novo and salvage pathways for nucleotide synthesis in normal and neoplastic tissues.
    Natsumeda Y; Prajda N; Donohue JP; Glover JL; Weber G
    Cancer Res; 1984 Jun; 44(6):2475-9. PubMed ID: 6327016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Potency of induced differentiation in vitro of a human promyelocytic leukemia cell mutant (HL-60-AR) with characteristics of resistance to 8-AG and deficiency in HGPRT].
    Liu YH; Xue SP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1986 Dec; 8(6):461-5. PubMed ID: 2954675
    [No Abstract]   [Full Text] [Related]  

  • 30. Cytotoxic and cytodifferentiative components of 6-thioguanine resistance in HL-60 cells containing acquired double minute chromosomes.
    Gallagher RE; Ferrari AC; Zulich AW; Yen RW; Testa JR
    Cancer Res; 1984 Jun; 44(6):2642-53. PubMed ID: 6586289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine.
    Zimm S; Johnson GE; Poplack DG
    Cancer Res; 1986 Dec; 46(12 Pt 1):6286-9. PubMed ID: 3465436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mode of action of 2-amino-6-chloro-1-deazapurine.
    Bennett LL; Smithers D; Rose LM; Adamson DJ; Brockman RW
    Biochem Pharmacol; 1984 Jan; 33(2):261-71. PubMed ID: 6142712
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biochemical genetics of Chinese hamster cell mutants with deviant purine metabolism: isolation, selection, and characterization of a mutant lacking hypoxanthine-guanine phosphoribosyltransferase activity by nutritional means.
    Patterson D; Jones C
    Somatic Cell Genet; 1976 Sep; 2(5):429-39. PubMed ID: 800293
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Salvage and interconversion of purines in developing Artemia.
    Rotllan P; Liras A; Llorente P
    Biochim Biophys Acta; 1993 Feb; 1156(2):128-34. PubMed ID: 8427871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reversion in expression of hypoxanthine-guanine phosphoribosyltransferase in 6-thioguanine resistant neuroblastoma: evidence for reduced enzyme levels associated with unaltered catalytic activity.
    Skaper SD; Spector EB; Seegmiller JE
    J Cell Physiol; 1977 Aug; 92(2):275-83. PubMed ID: 18484
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elucidation of aberrant purine metabolism: application to hypoxanthine-guanine phosphoribosylstransferase- and adenosine kinase-deficient mutants, and IMP dehydrogenase- and adenosine deaminase-inhibited human lymphoblasts.
    Snyder FF; Trafzer RJ; Hershfield MS; Seegmiller JE
    Biochim Biophys Acta; 1980 Oct; 609(3):492-501. PubMed ID: 6108130
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transfer of purine metabolites between cells through the medium and via cell contacts in cocultures of HGPRT+ and HGPRT- cells.
    Bols NC; Mosser DD; Boliska SA
    Exp Cell Res; 1987 Nov; 173(1):206-17. PubMed ID: 3678380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of GTP biosynthesis.
    Weber G; Nakamura H; Natsumeda Y; Szekeres T; Nagai M
    Adv Enzyme Regul; 1992; 32():57-69. PubMed ID: 1353938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical issues in chemotherapy with tiazofurin.
    Weber G
    Adv Enzyme Regul; 1989; 29():75-95. PubMed ID: 2699155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on the mechanism of 3-deazaguanine cytotoxicity in L1210-sensitive and -resistant cell lines.
    Singh G; Luna MK; Ardalan B
    Cancer Chemother Pharmacol; 1988; 22(3):191-6. PubMed ID: 2900700
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.